FDA Approves Hepcludex for Chronic Hepatitis D Treatment
The FDA has officially approved Hepcludex (bulevirtide-gmod) as the first therapeutic intervention for chronic hepatitis D virus (HDV) infection in adults with compensated liver disease. This milestone provides a vital ... Read More